Home

SI-BONE, Inc. - Common Stock (SIBN)

19.84
+0.96 (5.08%)
NASDAQ · Last Trade: May 16th, 2:06 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close18.88
Open18.90
Bid19.81
Ask19.85
Day's Range18.73 - 19.84
52 Week Range11.70 - 19.35
Volume422,156
Market Cap660.10M
PE Ratio (TTM)-31.00
EPS (TTM)-0.6
Dividend & YieldN/A (N/A)
1 Month Average Volume505,688

Chart

About SI-BONE, Inc. - Common Stock (SIBN)

Si-Bone Inc is a medical technology company focused on developing and commercializing innovative solutions for the treatment of musculoskeletal conditions, particularly those affecting the sacroiliac joint. The company specializes in minimally invasive surgical techniques and instruments that aim to alleviate pain and restore function for patients suffering from various spinal disorders. By leveraging advanced technology and evidence-based practices, Si-Bone seeks to improve patient outcomes while enhancing the efficiency of surgical procedures in the orthopedic field. Read More

News & Press Releases

4 Recent Earnings Winners Riding Fresh Momentum in May
Four companies experienced significant short-term rallies following better-than-expected earnings; can they maintain momentum going forward?
Via MarketBeat · May 14, 2025
Forecasting The Future: 6 Analyst Projections For SI-BONEbenzinga.com
Via Benzinga · May 6, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · May 5, 2025
Earnings Scheduled For May 5, 2025benzinga.com
Via Benzinga · May 5, 2025
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 14, 2025
Expert Outlook: SI-BONE Through The Eyes Of 5 Analystsbenzinga.com
Via Benzinga · February 25, 2025
The Analyst Verdict: SI-BONE In The Eyes Of 4 Expertsbenzinga.com
Via Benzinga · November 20, 2024
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Analyst Scoreboard: 4 Ratings For SI-BONEbenzinga.com
Via Benzinga · October 14, 2024
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 14, 2025
Earnings Scheduled For February 24, 2025benzinga.com
Via Benzinga · February 24, 2025
Analyst Ratings For SI-BONEbenzinga.com
Via Benzinga · August 6, 2024
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 16, 2025
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 16, 2025
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · January 13, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 18, 2024
These Analysts Cut Their Forecasts On SI-BONE Following Q2 Resultsbenzinga.com
Via Benzinga · August 6, 2024
A Closer Look at 6 Analyst Recommendations For SI-BONEbenzinga.com
Via Benzinga · May 7, 2024
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024investorplace.com
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024
7 Leading MedTech Stocks for Next-Gen Health Solutionsinvestorplace.com
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via InvestorPlace · July 31, 2024
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024investorplace.com
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · May 6, 2024
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insightsbenzinga.com
Via Benzinga · March 28, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · February 27, 2024
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stockbenzinga.com
Via Benzinga · February 27, 2024